Location of multiple binding sites for testo and testo–Pt(II) with tRNA

References

• Ahmed Ouameur, A., Bourassa, P., & Tajmir-Riahi, H. A. (2010). Probing tRNA interaction with biogenic polyamines. RNA, 16, 1968–1979.
   PubMed Web of Science ®Google Scholar
• Alex, S., & Dupuis, P. (1989). FTIR and Raman investigation of cadmium binding by DNA. Inorganica Chimica Acta, 157, 271–281.
   Web of Science ®Google Scholar
• Arya, S. K., & Yang, J. T. (1975). Interaction of steroids with nucleic acids. Biochemistry, 14, 963–969.
   PubMed Web of Science ®Google Scholar
• Bekale, L., Agudelo, D., & Tajmir-Riahi, H. A. (2015). Effect of polymer molecular weight on chitosan-protein interaction. Colloids Surfaces B, 125, 309–317.
   PubMed Web of Science ®Google Scholar
• Bekale, L., Chanphai, P., Sanyakamdhorn, S., Agudelo, D., & Tajmir-Riahi, H. A. (2014). Microscopic and thermodynamic analysis of PEG-lactoglobulin interaction. RSC Advances, 4, 31084–31093.
   Web of Science ®Google Scholar
• Bleczinski, C. F., & Richert, C. (1999). Steroid-DNA interactions increasing stablity, sequence selectivity, DNA/RNA discrimination, and hydrochromicity of oligonucleotide duplexes. Journal of the American Chemical Society, 121, 10889–10894.
   Web of Science ®Google Scholar
• Boss, A. (2016). Interaction of tea polyphenols with serum albumins: A fluorescence spectroscopic analysis. Journal of Luminescense., 169, 220–226.
   Web of Science ®Google Scholar
• Chandra, S., Dietrich, S., Lang, H., & Bahadur, D. (2011). Dendrimer–doxorubicin conjugate for enhanced therapeutic effects for cancer. Journal of Materials Chemistry, 21, 5729–5737.
   Web of Science ®Google Scholar
• Chanphai, P., Agudelo, D., Vesper, A. R., Bérubé, G., & Tajmir-Riahi, H. A. (2017a). Effect of testosterone and its aliphatic and aromatic dimers on DNA morphology. International Journal of Biological Macromolecules, 95, 850–855.
   PubMed Web of Science ®Google Scholar
• Chanphai, P., Agudelo, D., Vesper, A. R., Bérubé, G., & Tajmir-Riahi, H. A. (2017b). Testosterone and its dimers alter tRNA morphology. Journal of Pharmaceutical and Biomedical Analysis, 134, 269–274.
   PubMed Web of Science ®Google Scholar
• Connors, K. (1987). Binding constants: The measurement of molecular complex stability. New York: John Wiley & Sons.
   Google Scholar
• Cui, S., Wang, Y., & Chen, G. (2013). Disturbance of DNA conformation by the binding of testosterone-based platinum drugs via groove-face and intercalative interactions: A molecular dynamics simulation study. BMC Structural Biology, 13, 1–12.
   Web of Science ®Google Scholar
• Dasari, S., & Tchounwou, P. B. (2014). Cisplatin in cancer therapy: Molecular mechanisms of action. European Journal of Pharmacology, 740, 364–378.
   PubMed Web of Science ®Google Scholar
• Gupta, A., Mandal, S. K., Leblanc, V., Descôteaux, C., Asselin, E., & Bérubé, G. (2008). Synthesis and cytotoxic activity of benzopyran-based platinum(II) complexes. Bioorganic & Medicinal Chemistry Letters, 18, 3982–3987.
   PubMed Web of Science ®Google Scholar
• Hu, L., Chen, J., Zhang, F., Wang, J., Pan, J., Chen, J., & Wang, Y. (2017). Aberrant long noncoding RNAs expression profiles affect cisplatin resistance in lung adenocarcinoma. BioMed Research International, 2017, 7498151.
   PubMed Web of Science ®Google Scholar
• Hudson, W. H., Pickard, M. R., de Vera, I. M. S., Kuiper, E. G., Mourtada- Maarabouni, M., Conn, G. L., … Ortlund, A. E. (2015). Conserved sequence-specific lincRNA–steroid receptor interactions drive transcriptional repression and direct cell fate. Nature Communications, 5, 5395. doi: 10.1038/ncomms6395.
   Web of Science ®Google Scholar
• Hu, Y., Zhu, Q.-N., Deng, J. L., Li, Z.-X., Wang, G., & Zhu, Y.-S., (2018). Emerging role of long non-coding RNAs in cisplatin resistance. OncoTargets and Therapy, 11, 3185–3194.
   PubMed Web of Science ®Google Scholar
• Koch, S. C., Kuper, J., Gasteiger, K. L., Simon, N., Strasser, R., Eisen, D., … Carell, T. (2015). Structural insights into the recognition of cisplatin and Aaf-Dg lesion by Rad14 (Xpa). Proceedings of the National Academy of Sciences of the United States of America, 112, 8272.
   PubMed Web of Science ®Google Scholar
• Kung, J. T. Y., Colognori, D., & Lee, J. T. (2013). Long noncoding RNAs: Past, present, and future. Genetics, 193, 651–669.
   PubMed Web of Science ®Google Scholar
• Li, Q., Zhang, J., Zhou, J., Yang, B., Liu, P., Cao, L., … Liu, H. (2018). LncRNAs are novel biomarkers for differentiating between cisplatin-resistant and cisplatin-sensitive ovarian cancer. Oncology Letters, 15, 8363–8370.
   PubMed Web of Science ®Google Scholar
• Mandal, S., Bérubé, G., Asselin, E., Richardson, V. J., Church, J. G., Bridson, J., … Mandal, S. K. (2007). A new platinum complex of triazine demonstrates G1 arrest with novel biological profile in human breast cancer cell line, MDA-MB-468. Bioorganic & Medicinal Chemistry Letters, 17(8), 2139–2145.
   PubMed Web of Science ®Google Scholar
• Mandal, S., Moudgil, M., & Mandal, S. K. (2009). Rational drug design. European Journal of Pharmacology, 625(1–3), 90–100.
   PubMed Web of Science ®Google Scholar
• Marty, R., N’soukpoe-Kossi, C. N., Charbonneau, D., & Kreplak, L., Tajmir-Riahi, H. A. (2009). Structural characterization of cationic lipid–tRNA complexes. Nucleic Acids Research, 37, 5197–5207.
   PubMed Web of Science ®Google Scholar
• Melnikov, S. V., Söll, D., Steitz, T. A., & Polikanov, Y. S. (2016). Insights into RNA binding by the anticancer drug cisplatin from the crystal structure of cisplatin-modified ribosome. Nucleic Acids Research, 44(10), 4978–4987.
   PubMed Web of Science ®Google Scholar
• N’soukpoé-Kossi, C. N., Bourassa, P., Mandeville, J. S., & Tajmir-Riahi, H. A. (2014). Modelling of vitamin A binding to tRNA. Journal of Pharmaceutical and Biomedical Analysis, 99, 28–34.
   PubMed Web of Science ®Google Scholar
• Nafisi, S., & Norouzi, Z. (2009). A comparative study on the interaction of cis- and trans-platin with DNA and RNA. DNA and Cell Biology, 28, 469–477.
   PubMed Web of Science ®Google Scholar
• Neault, J. F., & Tajmir-Riahi, H. A. (1996). Diethylstilbestrol-DNA interaction studied by Fourier transform infrared and Raman spectroscopy. Journal of Biological Chemistry, 271, 8140–8143.
   PubMed Web of Science ®Google Scholar
• Neault, J. F., & Tajmir-Riahi, H. A. (1997). RNA-Diethylstilbestrol interaction studied by Fourier transform infrared difference spectroscopy. Journal of Biological Chemistry, 272, 8901–8904.
   PubMed Web of Science ®Google Scholar
• Oner, C., Coşan, D. T., E., & Colak, E. (2016). Estrogen and androgen hormone levels modulate the expression of PIWI interacting RNA in prostate and breast cancer. PLoS One, 11, e0159044.
   PubMed Web of Science ®Google Scholar
• Ouellette, V., Côté, M.-F., Gaudreault, R. C., Tajmir-Riahi, H. A., & Bérubé, G. (2018). 2nd Generation testosterone-platinum(II) hybrid molecules for site- specific treatment of androgen receptor positive prostate cancer: Design, synthesis and antiproliferative activity. (Manuscript in Preparation).
   Google Scholar
• Ross, P. D., & Subramanian, S. (1981). Thermodynamics of protein association reactions: Forces contributing to stability. Biochemistry, 20, 3096–3102.
   PubMed Web of Science ®Google Scholar
• Sanchez-Cano, C., Huxley, M., Ducani, C., Hamad, A. E., Browning, M. J., Navarro-Ranninger, C., … Hannon, M. J. (2010). Conjugation of testosterone modifies the interaction of mono-functional cationic platinum(II) complexes with DNA, causing significant alterations the DNA helix. Journal of the Chemical Society, Dalton Transactions, 39, 11365–11374.
   Google Scholar
• Scigress Explorer Ultra, Version: 7.7.0.47, Fujitsu.
   Google Scholar
• Wang, D., & Lippard, S. (2005). Cellular processing of platinum anticancer drugs. Nature Reviews Cancer, 4, 307–320.
   Google Scholar